• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Hero Background

    Molecular Diagnostics for Transplant Companies

    ID: MRFR/MED/10305-CR
    128 Pages
    Rahul Gotadki
    June 2023

    Molecular diagnostics for transplantation typically involves the use of genetic and molecular techniques to assess compatibility between donors and recipients, monitor transplant rejection, and optimize post-transplant care. Companies operating in this space may offer a range of products and services, including genetic testing, next-generation sequencing, and other advanced molecular diagnostic technologies.

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Top Industry Leaders in the Molecular Diagnostics for Transplant Market

    Molecular Diagnostics for Transplant Key Companies

     


    Latest Molecular Diagnostics for Transplant Companies Update:

    Natera Expanded its Prospera product line with Prospera with Quantification, the first commercially available cfDNA (cell-free DNA) test for non-invasive monitoring of kidney transplant rejection.


    CareDx Received FDA approval for AlloMap Heart Care™, a next-generation gene expression test that improves the prediction of cardiac allograft vasculopathy (CAV) development after heart transplant.


    Thermo Fisher Scientific Launched the TruSight Transplant One™ Kit, a comprehensive NGS (next-generation sequencing) assay enabling simultaneous analysis of HLA (human leukocyte antigen) typing, CMV (cytomegalovirus) and EBV (Epstein-Barr virus) detection, and chimerism testing in transplant patients.


    List of Molecular Diagnostics for Transplant Key companies in the market

    • Thermo Fisher Scientific Inc. (US)

    • BioMérieux SA (France)

    • Cepheid (US)

    • Altona Diagnostics GmbH (Germany)

    • ELITechGroup (France)

    • Hoffmann-La Roche Ltd. (Switzerland)

    • Hologic Inc. (US)

    • QIAGEN N.V. (Germany)

    • Becton, Dickinson, and Company (US)

    • Abbott Laboratories, Inc. (US)